Hi, today we are going to talk about Progenics Pharmaceuticals and its current landscape.
Progenics Pharmaceuticals, the oncology company, has received attention lately as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on the oncology sector. Progenics Pharmaceuticals has soared after unveiled that its late-stage trial of a treatment for prostate cancer met its primary goal, the data push the company forward, as the sector becomes more and more competitive.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Progenics Pharmaceuticals, the oncology company, has received attention lately as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on the oncology sector. Progenics Pharmaceuticals has soared after unveiled that its late-stage trial of a treatment for prostate cancer met its primary goal, the data push the company forward, as the sector becomes more and more competitive.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.